Rates set the tone
Rates ran the table. Treasury yields had their biggest one-day jump since 2022, and equities didn’t get a vote. When the discount rate moves like that, duration gets hit first and the market’s patience for “we’ll get there next quarter” disappears.
Fed messaging didn’t help. Comments attributed to Fed Chair Warsh flagged communication itself as a volatility source, which is another way of saying the market is trading the reaction function, not just the level. In that setup, the hurdle rate rises across the board: clean beats get paid, misses get punished, and “mixed” prints tend to leak.
AI demand holds
Even with the rate shock, the AI/infrastructure pocket held up better than the rest. Not a rip, just resilience. The story wasn’t “AI is back.” It was “AI has enough demand visibility to survive higher yields.”
Applied Materials (AMAT) posted Q4 results and raised guidance. In this tape, a guide-up matters more than a backward-looking beat because it signals order/backlog confidence, not accounting quality.
Cerebras Systems (CBRS) looked like a classic AI quarter: Q3 cloud revenue up 265% YoY, but it missed guidance while raising its forward outlook. The market will tolerate lumpiness if the forward path is clear—provided the company frames it proactively.
Cisco (CSCO) delivered the steadier enterprise read: Q1 above estimates and raised its FY27 outlook. Longer-dated outlook raises carry extra weight when yields are jumping because they help anchor the duration narrative.
AI demand wasn’t the problem. Pricing that demand through a higher discount-rate lens was. Visibility and guidance did the heavy lifting.
Microcaps stay binary
Small and microcap earnings traded like a referendum on the revenue line. With yields moving higher, there was little tolerance for gaps, cash-burn ambiguity, or anything that invites a financing conversation.
Punished
- MDxHealth (MDXH) fell after a double miss: Q3 GAAP EPS -$0.16 (miss $0.07) on revenue $22.71M (miss $5.52M). That revenue shortfall wasn’t subtle.
- Ensysce Biosciences (ENSC) dropped on an EPS miss: Q3 GAAP EPS -$4.52, miss $4.40. For early-stage biotech, a miss that wide immediately turns into a runway debate—and higher yields tighten that math.
- Virgin Galactic (SPCE) reported Q3 results and the stock declined. On a rates-led risk-off day, speculative duration is an easy source of supply.
Rewarded
- Liftoff Mobile (LIFT) worked on a clean two-line beat: Q3 GAAP EPS $0.47 (beat $0.30) and revenue $237.52M (beat $15.6M). Simple, decisive, and easy to underwrite.
- Birchtech (BTH) rose after beating both lines: Q3 GAAP EPS -$0.01 (beat $0.03) and revenue $5.5M (beat $1.3M). “Less bad plus better sales” still buys credibility in microcaps—at least for a session.
Flat/low signal
- New Concept Energy (GP) was flat: Q3 GAAP EPS $0.01, revenue $0.04M (too small to move the needle).
- Scribe Therapeutics (SCRB) was flat despite an EPS beat: Q3 GAAP EPS -$0.68 (beat $0.20), revenue $1.6M (miss $2.12M). Same message: revenue trajectory beats accounting optics.
- Birchcliff Energy (BIR) was flat: Q3 GAAP EPS $0.04 on revenue $190.03M. Energy usually needs a forward catalyst—commodity view or capital return—more than “fine numbers.”
What mattered
- The yield spike tightened the equity hurdle rate and hit duration first.
- Guidance and visibility held up best (AMAT, CSCO); lumpy quarters needed strong forward framing (CBRS).
- In small/microcaps, revenue misses were punished (MDXH, ENSC) and clean beats got paid (LIFT, BTH).
When rates lurch, the market stops debating stories and starts marking cash flows.